Literature DB >> 25111175

The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning.

Mónica B Jiménez-Castro1, Noelia Meroño1, Mariana Mendes-Braz1, Jordi Gracia-Sancho2, Laia Martínez-Carreres1, Maria Eugenia Cornide-Petronio1, Araní Casillas-Ramirez3, Juan Rodés4, Carmen Peralta5.   

Abstract

BACKGROUND & AIMS: Most liver grafts undergoing transplantation derive from brain dead donors, which may also show hepatic steatosis, being both characteristic risk factors in liver transplantation. Ischemic preconditioning shows benefits when applied in non-brain dead clinical situations like hepatectomies, whereas it has been less promising in the transplantation from brain dead patients. This study examined how brain death affects preconditioned steatotic and non-steatotic liver grafts undergoing transplantation.
METHODS: Steatotic and non-steatotic grafts from non-brain dead and brain dead-donors were cold stored for 6h and then transplanted. After 2, 4, and 16 h of reperfusion, hepatic damage was analysed. In addition, two therapeutic strategies, ischemic preconditioning and/or acetylcholine pre-treatment, and their underlying mechanisms were characterized.
RESULTS: Preconditioning benefits in non-brain dead donors were associated with nitric oxide and acetylcholine generation. In brain dead donors, preconditioning generated nitric oxide but did not promote acetylcholine upregulation, and this resulted in inflammation and damage. Acetylcholine treatment in brain dead donors, through PKC, increased antioxidants and reduced lipid peroxidation, nitrotyrosines and neutrophil accumulation, altogether protecting against damage. The combination of acetylcholine and preconditioning conferred stronger protection against damage, oxidative stress and neutrophil accumulation than acetylcholine treatment alone. These superior beneficial effects were due to a selective preconditioning-mediated generation of nitric oxide and regulation of PPAR and TLR4 pathways, which were not observed when acetylcholine was administered alone.
CONCLUSIONS: Our findings propose the combination of acetylcholine+preconditioning as a feasible and highly protective strategy to reduce the adverse effects of brain death and to ultimately improve liver graft quality.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholine; Brain death; Ischemic preconditioning; Liver transplantation; Nitric oxide; Steatotic liver grafts

Mesh:

Year:  2014        PMID: 25111175     DOI: 10.1016/j.jhep.2014.07.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  14 in total

1.  Neuroprotective effect of picroside II in brain injury in mice.

Authors:  Yida Wang; Wei Fang; Liang Wu; Xueya Yao; Suzhen Wu; Jie Wang; Zhen Xu; Fubo Tian; Zhenzhou He; Bin Dong
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

Review 3.  Brain death and marginal grafts in liver transplantation.

Authors:  M B Jiménez-Castro; J Gracia-Sancho; C Peralta
Journal:  Cell Death Dis       Date:  2015-06-04       Impact factor: 8.469

4.  The impact of cortisol in steatotic and non-steatotic liver surgery.

Authors:  María Eugenia Cornide-Petronio; Esther Bujaldon; Mariana Mendes-Braz; Cindy G Avalos de León; Mónica B Jiménez-Castro; Ana I Álvarez-Mercado; Jordi Gracia-Sancho; Juan Rodés; Carmen Peralta
Journal:  J Cell Mol Med       Date:  2017-04-04       Impact factor: 5.310

Review 5.  Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?

Authors:  Misaq Heydari; María Eugenia Cornide-Petronio; Mónica B Jiménez-Castro; Carmen Peralta
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

6.  The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death.

Authors:  Cindy G Avalos-de León; Mónica B Jiménez-Castro; María Eugenia Cornide-Petronio; José Gulfo; Floriana Rotondo; Jordi Gracia-Sancho; Araní Casillas-Ramírez; Carmen Peralta
Journal:  Cells       Date:  2019-12-14       Impact factor: 6.600

7.  Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway.

Authors:  Junhua Weng; Xin Wang; Baohong Xu; Wen Li
Journal:  Exp Ther Med       Date:  2021-06-10       Impact factor: 2.447

Review 8.  New Insights into the Liver-Visceral Adipose Axis During Hepatic Resection and Liver Transplantation.

Authors:  María Eugenia Cornide-Petronio; Mónica B Jiménez-Castro; Jordi Gracia-Sancho; Carmen Peralta
Journal:  Cells       Date:  2019-09-18       Impact factor: 6.600

9.  Microarray Analysis For Expression Profiles of lncRNAs and circRNAs in Rat Liver after Brain-Dead Donor Liver Transplantation.

Authors:  Sanyang Chen; Hongbo Fang; Jie Li; Jihua Shi; Jiakai Zhang; Peihao Wen; Zhihui Wang; Han Yang; Shengli Cao; Huapeng Zhang; Hongwei Tang; Wenzhi Guo; Shuijun Zhang
Journal:  Biomed Res Int       Date:  2019-11-07       Impact factor: 3.411

10.  Vagus Nerve Stimulation Alleviates Hepatic Ischemia and Reperfusion Injury by Regulating Glutathione Production and Transformation.

Authors:  Haoyang Xia; Zhongzhong Liu; Wenjin Liang; Xianpeng Zeng; Yi Yang; Pu Chen; Zibiao Zhong; Qifa Ye
Journal:  Oxid Med Cell Longev       Date:  2020-01-21       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.